Author

Xiang Li

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

ZCCHC10 as a novel prognostic biomarker associated with immune infiltration in breast cancer

It is suggested that ZCCHC10 serves as a prognostic biomarker and a key regulator of immune infiltration in breast cancer and Ipatasertib as a candidate targeted therapy requiring experimental verification.

Miao Chen, Si-Qi Wang, Xiang Li et al. · Scientific Reports · 0 citations